99 related articles for article (PubMed ID: 29871814)
21. A Dosimetric Analysis of Preoperative Intensity-modulated and Image-guided Radiation Therapy with and without Simultaneous Integrated Boost for Locally Advanced Rectal Cancer.
Yang Y; Feng L; Wang Y; Ge R; Gong H; Xie C; Wang J; Chen J; Lan Y; Ma L
Technol Cancer Res Treat; 2015 Oct; 14(5):557-63. PubMed ID: 24988052
[TBL] [Abstract][Full Text] [Related]
22. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation.
García-Albéniz X; Gallego R; Hofheinz RD; Fernández-Esparrach G; Ayuso-Colella JR; Bombí JA; Conill C; Cuatrecasas M; Delgado S; Ginés A; Miquel R; Pagés M; Pineda E; Pereira V; Sosa A; Reig O; Victoria I; Feliz L; María de Lacy A; Castells A; Burkholder I; Hochhaus A; Maurel J
World J Gastroenterol; 2014 Nov; 20(42):15820-9. PubMed ID: 25400468
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Eisterer W; Piringer G; DE Vries A; Öfner D; Greil R; Tschmelitsch J; Samonigg H; Sölkner L; Gnant M; Thaler J;
Anticancer Res; 2017 May; 37(5):2683-2691. PubMed ID: 28476845
[TBL] [Abstract][Full Text] [Related]
25. Preoperative tumour staging with multidisciplinary team assessment improves the outcome in locally advanced primary rectal cancer.
Palmer G; Martling A; Cedermark B; Holm T
Colorectal Dis; 2011 Dec; 13(12):1361-9. PubMed ID: 20958913
[TBL] [Abstract][Full Text] [Related]
26. Current issues of preoperative radio(chemo)therapy and its future evolution in locally advanced rectal cancer.
Ma B; Xu Q; Song Y; Gao P; Wang Z
Future Oncol; 2017 Nov; 13(27):2489-2501. PubMed ID: 29124955
[TBL] [Abstract][Full Text] [Related]
27. A Nomogram to Predict Lymph Node Positivity Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
Newton AD; Li J; Jeganathan AN; Mahmoud NN; Epstein AJ; Paulson EC
Dis Colon Rectum; 2016 Aug; 59(8):710-7. PubMed ID: 27384088
[TBL] [Abstract][Full Text] [Related]
28. Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary.
Marinello FG; Frasson M; Baguena G; Flor-Lorente B; Cervantes A; Roselló S; Espí A; García-Granero E
Dis Colon Rectum; 2015 Jun; 58(6):556-65. PubMed ID: 25944427
[TBL] [Abstract][Full Text] [Related]
29. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
[TBL] [Abstract][Full Text] [Related]
30. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
[TBL] [Abstract][Full Text] [Related]
31. Preoperative treatment with capecitabine, cetuximab and radiotherapy for primary locally advanced rectal cancer--a phase II clinical trial.
Eisterer W; De Vries A; Öfner D; Rabl H; Koplmüller R; Greil R; Tschmelitsch J; Schmid R; Kapp K; Lukas P; Sedlmayer F; Höfler G; Gnant M; Thaler J;
Anticancer Res; 2014 Nov; 34(11):6767-73. PubMed ID: 25368289
[TBL] [Abstract][Full Text] [Related]
32. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.
Garcia-Aguilar J; Chow OS; Smith DD; Marcet JE; Cataldo PA; Varma MG; Kumar AS; Oommen S; Coutsoftides T; Hunt SR; Stamos MJ; Ternent CA; Herzig DO; Fichera A; Polite BN; Dietz DW; Patil S; Avila K;
Lancet Oncol; 2015 Aug; 16(8):957-66. PubMed ID: 26187751
[TBL] [Abstract][Full Text] [Related]
33. CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer.
Shinto E; Hase K; Hashiguchi Y; Sekizawa A; Ueno H; Shikina A; Kajiwara Y; Kobayashi H; Ishiguro M; Yamamoto J
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S414-21. PubMed ID: 24566864
[TBL] [Abstract][Full Text] [Related]
34. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
Madbouly KM; Hussein AM; Abdelzaher E
Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
[TBL] [Abstract][Full Text] [Related]
35. IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists.
Desbois M; Le Vu P; Coutzac C; Marcheteau E; Béal C; Terme M; Gey A; Morisseau S; Teppaz G; Boselli L; Jacques Y; Béchard D; Tartour E; Cassard L; Chaput N
J Immunol; 2016 Jul; 197(1):168-78. PubMed ID: 27217584
[TBL] [Abstract][Full Text] [Related]
36. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
Zhan T; Gu J; Li M; Du C
Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609
[TBL] [Abstract][Full Text] [Related]
37. Clinical outcome of neoadjuvant chemoradiation in locally advanced rectal cancer at a tertiary hospital.
Yeung WW; Ma BB; Lee JF; Ng SS; Cheung MH; Ho WM; Tsang MW; Chu S; Lam DC; Mo FK
Hong Kong Med J; 2016 Dec; 22(6):546-55. PubMed ID: 27795447
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant Combined-Modality Therapy for Locally Advanced Rectal Cancer and Its Future Direction.
Salem ME; Hartley M; Unger K; Marshall JL
Oncology (Williston Park); 2016 Jun; 30(6):546-62. PubMed ID: 27306709
[TBL] [Abstract][Full Text] [Related]
39. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
[TBL] [Abstract][Full Text] [Related]
40. Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment?
Lombardi R; Cuicchi D; Pinto C; Di Fabio F; Iacopino B; Neri S; Tardio ML; Ceccarelli C; Lecce F; Ugolini G; Pini S; Di Tullio P; Taffurelli M; Minni F; Martoni A; Cola B
Ann Surg Oncol; 2010 Mar; 17(3):838-45. PubMed ID: 20012700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
